Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-30)

In this article we will discuss Durvalumab (Warnings-30)

In this article, we will discuss Durvalumab (Warnings-30). So, let’s get started.

Ocular: Uveitis, iritis, and other ocular inflammatory toxicities can occur. Some cases can be associated with retinal detachment. Various grades of visual impairment to include blindness can occur. If uveitis occurs in combination with other immune-mediated adverse reactions, consider a Vogt-Koyanagi-Harada- like syndrome, as this may require treatment with systemic steroids to reduce the risk of permanent vision loss.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.